Conjugated bile acid–activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression
暂无分享,去创建一个
S. Spiegel | Runping Liu | P. Hylemon | K. Takabe | J. Allegood | Jie Liang | W. Pandak | Huiping Zhou | Xiang Wang | M. Nagahashi | N. Hait | Kesong Peng | A. Yamada | Yun Wang | T. Aoyagi | Xuan Wang
[1] P. Edwards,et al. Pleiotropic roles of bile acids in metabolism. , 2013, Cell metabolism.
[2] Zachary Smith,et al. Epigenomic regulation of bile acid metabolism: Emerging role of transcriptional cofactors , 2013, Molecular and Cellular Endocrinology.
[3] P. Hylemon,et al. The role of CCAAT enhancer‐binding protein homologous protein in human immunodeficiency virus protease‐inhibitor–induced hepatic lipotoxicity in mice , 2013, Hepatology.
[4] Y. Inoue,et al. Antagonism of sphingosine 1‐phosphate receptor 2 causes a selective reduction of portal vein pressure in bile duct‐ligated rodents , 2012, Hepatology.
[5] S. Kliewer,et al. Endocrine fibroblast growth factors 15/19 and 21: from feast to famine. , 2012, Genes & development.
[6] S. Spiegel,et al. Conjugated bile acids activate the sphingosine‐1‐phosphate receptor 2 in primary rodent hepatocytes , 2012, Hepatology.
[7] M. Stepanova,et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[8] Lixin Sun,et al. Bile acids regulate hepatic gluconeogenic genes and farnesoid X receptor via Gαi-protein-coupled receptors and the AKT pathway[S] , 2010, Journal of Lipid Research.
[9] Sarah Spiegel,et al. Estradiol Induces Export of Sphingosine 1-Phosphate from Breast Cancer Cells via ABCC1 and ABCG2* , 2010, The Journal of Biological Chemistry.
[10] S. Mohanty,et al. Nonalcoholic Fatty Liver Disease: A Review and Update , 2010, Digestive Diseases and Sciences.
[11] J. Chiang,et al. Bile acids: regulation of synthesis , 2009, Journal of Lipid Research.
[12] S. Milstien,et al. Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate , 2009, Science.
[13] A. Feldstein,et al. Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal , 2009, Expert review of gastroenterology & hepatology.
[14] P. Dent,et al. Bile acids as regulatory molecules , 2009, Journal of Lipid Research.
[15] F. Nicoletti,et al. Molecular mechanisms involved in NAFLD progression , 2009, Journal of Molecular Medicine.
[16] J. Kountouras,et al. Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. , 2009, Current molecular medicine.
[17] H. Tilg,et al. Insulin resistance, inflammation, and non-alcoholic fatty liver disease , 2008, Trends in Endocrinology & Metabolism.
[18] Johan Auwerx,et al. Targeting bile-acid signalling for metabolic diseases , 2008, Nature Reviews Drug Discovery.
[19] S. Milstien,et al. “Inside-Out” Signaling of Sphingosine-1-Phosphate: Therapeutic Targets , 2008, Pharmacological Reviews.
[20] Ming Yan,et al. Prevention of free fatty acid–induced hepatic lipotoxicity by 18β‐glycyrrhetinic acid through lysosomal and mitochondrial pathways , 2008, Hepatology.
[21] P. Edwards,et al. FXR signaling in metabolic disease , 2008, FEBS letters.
[22] N. Mitro,et al. Lipid sensing and lipid sensors , 2007, Cellular and Molecular Life Sciences.
[23] J. Chun,et al. The sphingosine 1‐phosphate receptor S1P2 triggers hepatic wound healing , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[24] S. Milstien,et al. Sphingosine Kinase Type 2 Activation by ERK-mediated Phosphorylation* , 2007, Journal of Biological Chemistry.
[25] P. Hylemon,et al. HIV Protease Inhibitors Activate the Unfolded Protein Response in Macrophages: Implication for Atherosclerosis and Cardiovascular Disease , 2005, Molecular Pharmacology.
[26] M. Maceyka,et al. Sphingosine kinases, sphingosine-1-phosphate and sphingolipidomics. , 2005, Prostaglandins & other lipid mediators.
[27] M. Karin,et al. Redundant pathways for negative feedback regulation of bile acid production. , 2002, Developmental cell.
[28] L. Moore,et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. , 2000, Molecular cell.
[29] T. A. Kerr,et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. , 2000, Molecular cell.
[30] W. Pandak,et al. Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: In vitro studies in rat hepatocytes and human erythrocytes , 1991, Hepatology.
[31] D. Heuman,et al. Regulation of bile acid synthesis. I. Effects of conjugated ursodeoxycholate and cholate on bile acid synthesis in chronic bile fistula rat , 1988, Hepatology.
[32] J. Folch,et al. A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.
[33] M. Maceyka,et al. Extracellular and intracellular actions of sphingosine-1-phosphate. , 2010, Advances in experimental medicine and biology.
[34] B. Staels,et al. Role of bile acids and bile acid receptors in metabolic regulation. , 2009, Physiological reviews.
[35] C. Aguilar-Salinas,et al. Metabolic syndrome and non-alcoholic fatty liver disease. , 2009, Annals of hepatology.
[36] N. Mitro,et al. Bile acids and their signaling pathways: eclectic regulators of diverse cellular functions. , 2007, Cellular and molecular life sciences : CMLS.